Diagnexia

Company profile

About Diagnexia

Diagnexia operates as a comprehensive digital pathology department, connecting healthcare organisations with an international network of GMC-registered, subspecialty-trained pathologists. The company provides end-to-end histopathology services including primary diagnostic reporting, secondary expert consultations, and External Quality Assurance (EQA) programmes. Founded to address the critical pathology workforce shortage, Diagnexia combines digital pathology infrastructure with expert clinical capacity to help NHS trusts and health systems clear backlogs, balance workloads, and improve patient outcomes. The platform features fully digital workflows with integrated synoptic reporting, seamless LIS integration, and comprehensive case management. Diagnexia maintains UKAS accreditation to ISO 15189:2022 for its Oxford histology laboratory, CQC registration for facilities in Oxford and Exeter, and participates in NEQAS/EQA schemes. The company serves the UK market through the NHS National Framework Agreement and operates CLIA-registered facilities in the United States and Canada. With average turnaround times of 1.5 days for primary reporting and 4.0 days for secondary consults, Diagnexia addresses the critical gap where 97% of NHS histopathology departments operate understaffed with 200-300 consultant vacancies nationwide. The service is supported by dedicated case management teams and robust digital integration systems designed specifically for rapid, reliable pathology reporting.

Company description · Diagnexia official website